HANGZHOU TIGERMED CONSULTING CO LTD
(HKEX: 3347)

Hangzhou Tigermed Consulting Co., Ltd. provides clinical research services for research and development of domestic and foreign pharmaceutical and health related products. Its services include technical services for phase I to phase IV clinical trials, registration and declaration of clinical trials, on-site services, as well as data management and analysis, etc. The company was founded on December 15, 2004 and is headquartered in Hangzhou, China.

36.020 -

-2.000 (-5.26%)
Range 34.380 - 37.500   (9.08%)
Open 35.520
Previous Close 38.020
Bid Price 36.020
Bid Volume ('000) 0.4
Ask Price 36.080
Ask Volume ('000) 2.4
Volume ('000) 7,349.6
Value 262,112,602
Remark -
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis